Trajectory, risk factors, and impact of abdominal pain during the first year after pediatric IBD diagnosis: Results from the ImproveCareNow Network
Murphy L, Gashi K, Kawamura J, Zhou C, Lynch D, Suskind D, Palermo T. Trajectory, risk factors, and impact of abdominal pain during the first year after pediatric IBD diagnosis: Results from the ImproveCareNow Network. NASPGHAN Annual Meeting, Chicago, IL 2019
Reduction in corticosteroid usage among pediatric patients with inflammatory bowel disease in a large learning health system
Kandavel P, Adler J, Meister S. Reduction in corticosteroid usage among pediatric patients with inflammatory bowel disease in a large learning health system. NASPGHAN Annual Meeting, Chicago, IL 2019
Insurance status but not race determines sustained remission in pediatric IBD
Doan S, Jofriet A, Scott O, Riswan A, Venkateswaran S, Somineni H, Niklinska-Schirtz B, Talmadge C, Fritzen C, Dinser M, Dykes D, Gold B, Sauer C, Kugathasan S, Schoen B. Insurance status but not race determines sustained remission in pediatric IBD. NASPGHAN Annual Meeting, Chicago, IL 2019
Anemia prevalence in pediatrics IBD: Still persisted after 1 year
Malik P, Kim M, Puopolo G, Thompson J, Tomer G. Anemia prevalence in pediatrics IBD: Still persisted after 1 year. NASPGHAN Annual Meeting, Chicago, IL 2019
Hospitalizations in children with inflammatory bowel disease
Alper A, Algara M, Phatak U, Pashankar D. Hospitalizations in children with inflammatory bowel disease. NASPGHAN Annual Meeting, Chicago, IL 2019